ArticleFrontiers in oncology2026

A prospective, multi-center, phase IV clinical study to assess the safety and clinical outcome of acalabrutinib in Indian adult patients with chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed/refractory mantle cell lymphoma.

Pankaj Malhotra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.